Published in
Elsevier, Annals of Oncology, 9(31), p. 1251-1259, 2020
DOI: 10.1016/j.annonc.2020.05.016
Links
Tools
Favourable Outcomes for High-Risk Diffuse Large B-Cell Lymphoma (IPI 3-5) Treated with Front-Line R-CODOX-M/R-IVAC Chemotherapy: Results of a Phase 2 UK NCRI Trial
Journal article published in 2020 by
A. K. McMillan,
E. H. Phillips 
,
A. A. Kirkwood,
S. Barrans,
C. Burton,
S. Rule,
R. Patmore,
R. Pettengell,
K. M. Ardeshna,
A. Lawrie,
S. Montoto,
S. Paneesha,
L. Clifton-Hadley,
D. C. Linch
,
A. A. Kirkwood,
S. Barrans,
C. Burton,
S. Rule,
R. Patmore,
R. Pettengell,
K. M. Ardeshna,
A. Lawrie,
S. Montoto,
S. Paneesha,
L. Clifton-Hadley,
D. C. Linch
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 